Caring for patients using mitragynine-derived substances

Familiarize yourself with the differences in mitragynine-derived compounds. Understand how to identify and manage kratom use disorder and withdrawal from mitragynine-derived compounds. We’re joined by Dr. Jonathan Tanawan (Profile).   

Claim CME for this episode at !
By listening to this episode and completing CME, this can be used to count towards the new DEA 8-hr requirement on substance use disorders education.

Episodes | Subscribe | Spotify | iTunes | CurbsidersAddictionMed@gmail.com | CME!

Credits

  • Written and Produced, with  Show Notes, Infographic, and Cover Art by Zina Huxley-Reicher, MD 
  • Hosts: Carolyn Chan, MD. MHS and Zina Huxley-Reicher, MD
  • Reviewer: Kento Sonoda, MD, MPH
  • Showrunner: Carolyn Chan, MD, MHS
  • Technical Production: PodPaste
  • Guest: Jonathan Tanawan, MD

Show Segments

  • Intro, disclaimer, guest bio
  • Guest one-liner, Picks of the Week*
  • Case from Kashlak; Definitions
  • Pharmacology of  kratom and other mitragynine-based compounds
  • How to take a mitragynine-specific substance use history
  • Defining a use disorder
  • Withdrawal from kratom 
  • Managing a use disorder with MOUD
  • Legal landscape and regulation 
  • Outro


Sponsor: Freed

Go to freed.ai and use code FREED50 for fifty dollars off your first month. 

Sponsor: Figs

Curbsiders listeners can get 15% off. Just go to and use code FIGSRX.  

Sponsor: Continuing Education Company

Visit CMEmeeting.org/curbsiders and use promo code Curb30 for 30% off all online courses and webcasts.

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör The Curbsiders Internal Medicine Podcast. Innehållet i podden är skapat av The Curbsiders Internal Medicine Podcast och inte av, eller tillsammans med, Poddtoppen.